Opportunity Information: Apply for RFA CK 16 00103CONT18
The Emerging Infectious Sentinel Networks (EISN) Research opportunity is a Centers for Disease Control and Prevention (CDC) funding announcement that supports ongoing work under an existing EISN cooperative agreement. It is specifically a FY2018 noncompetitive continuation solicitation, meaning it is not an open, stand-alone competition for new applicants. Instead, it is designed to provide continued support to organizations that were already selected and funded under the earlier CDC announcement RFA-CK-16-001, which established the EISN research effort. In practical terms, the opportunity exists to let current awardees submit continuation materials and receive the next increment of funding to keep the approved project activities moving forward without launching a new competitive review process.
This continuation is issued as a cooperative agreement, which typically indicates substantial CDC involvement in the funded work compared with a standard grant. Under a cooperative agreement structure, recipients generally carry out the day-to-day project operations, while CDC may provide scientific and programmatic input, coordination, technical assistance, or collaboration to help ensure the project aligns with public health priorities and produces useful, actionable outputs. The activity category is health, and it is associated with CFDA number 93.860, reflecting the public health and infectious disease focus of the program. The opportunity is listed under CDC (ERA), pointing to CDCs electronic research administration context for application and award management.
Eligibility is effectively restricted to previous recipients (even though the listing may show a broad label such as "Others"), because the description states the funds are intended only for organizations previously awarded under RFA-CK-16-001. That is the defining feature of a noncompetitive continuation: only current awardees are expected to apply, and the application typically functions as a progress-and-plans submission rather than a brand-new proposal. The original closing date for this continuation action was January 24, 2018, and the opportunity record was created on November 3, 2017, which fits a standard federal timeline for preparing and processing continuation awards for the next budget period.
Several fields in the source data signal that the listing is primarily administrative rather than a fresh funding competition. For example, the award ceiling is shown as 0 and the expected awards field is blank, which is common in continuation notices because the funding amounts and number of continuation actions depend on existing awards, available appropriations, and each recipients approved budget and performance. In other words, the notice is best understood as the formal mechanism CDC uses to continue funding the existing EISN research network activities for FY2018, contingent on acceptable progress, continued program relevance, and the availability of funds, rather than an invitation for new entities to apply to start EISN projects.Apply for RFA CK 16 00103CONT18
- The Centers for Disease Control and Prevention - ERA in the health sector is offering a public funding opportunity titled "Emerging Infectious Sentinel Networks (EISN) Research" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.860.
- This funding opportunity was created on 2017-11-03.
- Applicants must submit their applications by 2018-01-24. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Transition to Independent Environmental Health Research (TIEHR) Career Transition Award (K01 Clinical Trial Required)
Previous opportunity: Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 16 00103CONT18
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 16 00103CONT18) also looked into and applied for these:
| Funding Opportunity |
|---|
| NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Apply for PAR 18 118 Funding Number: PAR 18 118 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) Apply for PA 18 288 Funding Number: PA 18 288 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Population-based HIV Impact Assessments in Resource-Constrained Settings under the President’s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409A Funding Number: CDC RFA GH14 1409A Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R03 Clinical Trial Required) Apply for PA 18 198 Funding Number: PA 18 198 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R21 Clinical Trial Required) Apply for PA 18 197 Funding Number: PA 18 197 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Systems Biology Approaches using Non-Mammalian Laboratory Animals to Uncover Causes of Neurodegeneration that Might Underlie Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed) Apply for RFA AG 18 021 Funding Number: RFA AG 18 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R03 Clinical Trial Optional) Apply for PA 18 200 Funding Number: PA 18 200 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R03 Clinical Trial Optional) Apply for PA 18 201 Funding Number: PA 18 201 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R21 Clinical Trial Optional) Apply for PA 18 202 Funding Number: PA 18 202 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Human Studies to Evaluate Promising Medications to Treat Alcohol Use Disorder (R01 Clinical Trial Required) Apply for PA 18 192 Funding Number: PA 18 192 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R01 Clinical Trial Optional) Apply for PA 18 193 Funding Number: PA 18 193 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alcohol Use Disorders: Behavioral Treatment, Services and Recovery Research (R01 Clinical Trial Optional) Apply for PA 18 194 Funding Number: PA 18 194 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening and Brief Alcohol Interventions in Underage and Young Adult Populations (R21 Clinical Trial Optional) Apply for PA 18 199 Funding Number: PA 18 199 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mechanisms of Disparities for HIV- Related Co-morbidities in Health Disparity Populations (R01-Clinical Trial Not Allowed) Apply for RFA MD 18 002 Funding Number: RFA MD 18 002 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| NIMH Exploratory/Developmental Research Grant (R21 - Clinical Trial Not Allowed) Apply for PA 18 350 Funding Number: PA 18 350 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Selected Topics in Transfusion Medicine (R01 Clinical Trial Optional) Apply for PAR 18 126 Funding Number: PAR 18 126 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Neural Devices (UG3/UH3 - Clinical Trial Required) Apply for RFA NS 18 011 Funding Number: RFA NS 18 011 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) Apply for PAR 18 174 Funding Number: PAR 18 174 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Selected Topics in Transfusion Medicine (R21 Clinical Trial Optional) Apply for PAR 18 132 Funding Number: PAR 18 132 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Translational Neural Devices (U44 - Clinical Trial Required) Apply for RFA NS 18 012 Funding Number: RFA NS 18 012 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 16 00103CONT18", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.